» Articles » PMID: 33563294

Rabbit Thyroid Extracellular Matrix As a 3D Bioscaffold for Thyroid Bioengineering: A preliminary in vitro study

Overview
Publisher Biomed Central
Date 2021 Feb 10
PMID 33563294
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in regenerative medicine technologies have been strongly proposed in the management of thyroid diseases. Mechanistically, the adoption of thyroid bioengineering requires a scaffold that shares a similar three-dimensional (3D) space structure, biomechanical properties, protein component, and cytokines to the native extracellular matrix (ECM).

Methods: 24 male New Zealand white rabbits were used in this experimental study. The rabbit thyroid glands were decellularized by immersion/agitation decellularization protocol. The 3D thyroid decellularization scaffolds were tested with histological and immunostaining analyses, scanning electron microscopy, DNA quantification, mechanical properties test, cytokine assay and cytotoxicity assays. Meanwhile, the decellularization scaffold were seeded with human thyroid follicular cells, cell proliferation and thyroid peroxidase were determined to explore the biocompatibility in vitro.

Results: Notably, through the imaging studies, it was distinctly evident that our protocol intervention minimized cellular materials and maintained the 3D spatial structure, biomechanical properties, ECM composition, and biologic cytokine. Consequently, the decellularization scaffold was seeded with human thyroid follicular cells, thus strongly revealing its potential in reinforcing cell adhesion, proliferation, and preserve important protein expression.

Conclusions: The adoption of our protocol to generate a decellularized thyroid scaffold can potentially be utilized in transplantation to manage thyroid diseases through thyroid bioengineering.

Citing Articles

Bioengineering liver tissue by repopulation of decellularised scaffolds.

Afzal Z, Huguet E World J Hepatol. 2023; 15(2):151-179.

PMID: 36926238 PMC: 10011915. DOI: 10.4254/wjh.v15.i2.151.


From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics.

Heim M, Nixon I, Emmerson E, Callanan A Front Endocrinol (Lausanne). 2022; 13:997288.

PMID: 36277721 PMC: 9581390. DOI: 10.3389/fendo.2022.997288.


Recent Advances in Liver Engineering With Decellularized Scaffold.

Dai Q, Jiang W, Huang F, Song F, Zhang J, Zhao H Front Bioeng Biotechnol. 2022; 10:831477.

PMID: 35223793 PMC: 8866951. DOI: 10.3389/fbioe.2022.831477.

References
1.
Iwadate M, Takizawa Y, Shirai Y, Kimura S . An in vivo model for thyroid regeneration and folliculogenesis. Lab Invest. 2018; 98(9):1126-1132. PMC: 6138525. DOI: 10.1038/s41374-018-0068-x. View

2.
Li Y, Xu Y, Liu Y, Wang Z, Chen W, Duan L . Decellularized cartilage matrix scaffolds with laser-machined micropores for cartilage regeneration and articular cartilage repair. Mater Sci Eng C Mater Biol Appl. 2019; 105:110139. DOI: 10.1016/j.msec.2019.110139. View

3.
Cortiella J, Niles J, Cantu A, Brettler A, Pham A, Vargas G . Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A. 2010; 16(8):2565-80. DOI: 10.1089/ten.tea.2009.0730. View

4.
Wong M, Wong J, Vapniarsky N, Griffiths L . In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation. Biomaterials. 2016; 92:1-12. PMC: 5289067. DOI: 10.1016/j.biomaterials.2016.03.024. View

5.
Ott H, Matthiesen T, Goh S, Black L, Kren S, Netoff T . Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008; 14(2):213-21. DOI: 10.1038/nm1684. View